These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33264726)

  • 1. Generation of a human induced pluripotent stem cell line (SBWCHi001-A) from a patient with NEDSDV carrying a pathogenic mutation in CTNNB1 gene.
    Yan R; Liu P; Li F; Chu M; Lei J; Wang F; Luo L; Xu X
    Stem Cell Res; 2020 Dec; 49():102091. PubMed ID: 33264726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi055-A from a patient with NEDSDV carrying a heterozygote mutation in the CTNNB1 gene.
    Yang Y; Liu C; Liu N; Yang X; Liu Y; Gai Z
    Stem Cell Res; 2024 Apr; 76():103335. PubMed ID: 38364504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital heart defects in CTNNB1 syndrome: Raising clinical awareness.
    Sinibaldi L; Garone G; Mandarino A; Iarossi G; Chioma L; Dentici ML; Merla G; Agolini E; Micalizzi A; Mancini C; Niceta M; Macchiaiolo M; Diodato D; Onesimo R; Blandino R; Delogu AB; De Rosa G; Trevisan V; Iademarco M; Zampino G; Tartaglia M; Novelli A; Bartuli A; Digilio MC; Calcagni G
    Clin Genet; 2023 Nov; 104(5):528-541. PubMed ID: 37455656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel CTNNB1 variant leading to neurodevelopmental disorder with spastic diplegia and visual defects plus peripheral neuropathy: A case report.
    Spagnoli C; Salerno GG; Rizzi S; Frattini D; Koskenvuo J; Fusco C
    Am J Med Genet A; 2022 Oct; 188(10):3118-3120. PubMed ID: 35880249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants.
    Kayumi S; Pérez-Jurado LA; Palomares M; Rangu S; Sheppard SE; Chung WK; Kruer MC; Kharbanda M; Amor DJ; McGillivray G; Cohen JS; García-Miñaúr S; van Eyk CL; Harper K; Jolly LA; Webber DL; Barnett CP; Santos-Simarro F; Pacio-Míguez M; Pozo AD; Bakhtiari S; Deardorff M; Dubbs HA; Izumi K; Grand K; Gray C; Mark PR; Bhoj EJ; Li D; Ortiz-Gonzalez XR; Keena B; Zackai EH; Goldberg EM; Perez de Nanclares G; Pereda A; Llano-Rivas I; Arroyo I; Fernández-Cuesta MÁ; Thauvin-Robinet C; Faivre L; Garde A; Mazel B; Bruel AL; Tress ML; Brilstra E; Fine AS; Crompton KE; Stegmann APA; Sinnema M; Stevens SCJ; Nicolai J; Lesca G; Lion-François L; Haye D; Chatron N; Piton A; Nizon M; Cogne B; Srivastava S; Bassetti J; Muss C; Gripp KW; Procopio RA; Millan F; Morrow MM; Assaf M; Moreno-De-Luca A; Joss S; Hamilton MJ; Bertoli M; Foulds N; McKee S; MacLennan AH; Gecz J; Corbett MA
    Genet Med; 2022 Nov; 24(11):2351-2366. PubMed ID: 36083290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and clinical characteristics of 24 mainland Chinese patients with CTNNB1 loss-of-function variants.
    Yan D; Sun Y; Xu N; Yu Y; Zhan Y;
    Mol Genet Genomic Med; 2022 Nov; 10(11):e2067. PubMed ID: 36153650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A de novo
    Verhoeven WMA; Egger JIM; Jongbloed RE; van Putten MM; de Bruin-van Zandwijk M; Zwemer AS; Pfundt R; Willemsen MH
    Int Med Case Rep J; 2020; 13():487-492. PubMed ID: 33116939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Startle Disease: An Overlooked Symptom of
    Bulot V; Ramond F; Mauguière F; Mazzola L
    Neurol Genet; 2022 Dec; 8(6):e200039. PubMed ID: 36419413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: A
    Ke Z; Chen Y
    Front Pediatr; 2020; 8():575673. PubMed ID: 33425807
    [No Abstract]   [Full Text] [Related]  

  • 10. Establishment of human induced pluripotent stem cell line (SDQLCHi060-A) from a patient with AUTS2 syndrome carrying a heterozygous mutation in AUTS2 gene.
    Gao C; Liu Y; Liu N; Li Z; Yang X; Yang Y; Xi Y; Tian J; Gai Z
    Stem Cell Res; 2023 Dec; 73():103242. PubMed ID: 37948839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia areata-like pattern of baldness: the most recent update and the expansion of novel phenotype and genotype in the CTNNB1 gene.
    Moeinafshar A; Tehrani Fateh S; Sadeghi H; Karimzadeh P; Mirfakhraie R; Hashemi-Gorji F; Larki P; Miryounesi M; Ghasemi MR
    Neurol Sci; 2023 Nov; 44(11):4041-4048. PubMed ID: 37369877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an induced pluripotent stem cell line (SDQLCHi044-A) from a patient with autosomal dominant mental retardation type 5 harboring heterozygous mutation in SYNGAP1 gene.
    Wang Y; Lv Y; Yang X; Li Y; Li Z; Gao Z; Gai Z; Liu Y
    Stem Cell Res; 2022 Oct; 64():102922. PubMed ID: 36183676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTNNB1-related neurodevelopmental disorder in a Chinese population: A case series.
    Ho S; Tsang MH; Fung JL; Huang H; Chow CB; Cheng SS; Luk HM; Chung BH; Lo IF
    Am J Med Genet A; 2022 Jan; 188(1):130-137. PubMed ID: 34558805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing identifies a de novo mutation of CTNNB1 gene in a patient mainly presented with retinal detachment, lens and vitreous opacities, microcephaly, and developmental delay: Case report and literature review.
    Li N; Xu Y; Li G; Yu T; Yao RE; Wang X; Wang J
    Medicine (Baltimore); 2017 May; 96(20):e6914. PubMed ID: 28514307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an induced pluripotent stem cell line (SDQLCHi067-A) from a patient with subcortical band heterotopia harboring a heterozygous mutation in DCX gene.
    Gao C; Yang X; Yang Y; Liu N; Li Y; Liu Y; Gai Z
    Stem Cell Res; 2024 Apr; 76():103356. PubMed ID: 38402847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missense variants in CTNNB1 can be associated with vitreoretinopathy-Seven new cases of CTNNB1-associated neurodevelopmental disorder including a previously unreported retinal phenotype.
    Rossetti LZ; Bekheirnia MR; Lewis AM; Mefford HC; Golden-Grant K; Tarczy-Hornoch K; Briere LC; Sweetser DA; Walker MA; Kravets E; Stevenson DA; Bruenner G; Sebastian J; Knapo J; Rosenfeld JA; Marcogliese PC; ; Wangler MF
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1542. PubMed ID: 33350591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a human induced pluripotent stem cell line（SDQLCHi059-A）from a patient with congenital disorder of glycosylation carrying heterozygous mutation in MPI gene.
    Wang B; Yang L; Gao M; Zhang H; Liu Y; Gai Z
    Stem Cell Res; 2024 Jun; 77():103381. PubMed ID: 38493608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cell (iPSC) lines carrying a heterozygous (UKWMPi002-A-1) and null mutant knockout (UKWMPi002-A-2) of Cadherin 13 associated with neurodevelopmental disorders using CRISPR/Cas9.
    Vitale MR; Zöller JEM; Jansch C; Janz A; Edenhofer F; Klopocki E; van den Hove D; Vanmierlo T; Rivero O; Nadif Kasri N; Ziegler GC; Lesch KP
    Stem Cell Res; 2021 Mar; 51():102169. PubMed ID: 33486346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a human induced pluripotent stem cell line (UQACi001-A) from a severe epidermolysis bullosa simplex patient with the heterozygous mutation p.R125S in the KRT14 gene.
    Bchetnia M; Martineau L; Racine V; Powell J; McCuaig C; Puymirat J; Laprise C
    Stem Cell Res; 2020 Apr; 44():101748. PubMed ID: 32179493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a human induced pluripotent stem cell line (SJTUXHi002-A) from an individual with autism spectrum disorder carrying a heterozygous mutation in GRIA2.
    Ji Y; Lv H; Chen Z; Yu J; Fang S; Li F
    Stem Cell Res; 2022 Apr; 60():102676. PubMed ID: 35134694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.